Key result
Low vitamin D in COPD is strongly linked to more exacerbations, higher hs-CRP, and worse symptoms.
Why the study?
Vitamin D deficiency has been suggested to contribute to COPD inflammation and exacerbations, but its association with systemic inflammation and exacerbation frequency in COPD GOLD group E needed investigation.
Are low serum vitamin D levels associated with increased systemic inflammation and exacerbation frequency in patients with COPD GOLD group E?
Population
111 patients with stable COPD
Comparison
Serum 25(OH)D <50 nmol/L vs ≥50 nmol/L
Design
Cross-sectional study
Authors
Loading...
Hypothesis-generating for vitamin D repletion in COPD GOLD E; prospective trials needed before clinical adoption.
Are low serum vitamin D levels associated with increased systemic inflammation and exacerbation frequency in patients with COPD GOLD group E?
In patients with COPD GOLD group E, low vitamin D levels are strongly associated with greater symptom burden, systemic inflammation, and more frequent exacerbations.
Sioutas et al. (2026) studied this question. Low serum vitamin D (<50 nmol/L) in COPD GOLD group E patients was strongly associated with increased exacerbation frequency (r = -0.74), elevated hs-CRP, and higher symptom burden.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: